Allosteric modulation of SHP2: Quest from known to unknown
Drug Development Research · 2023-11 · 84 (7) · 1395-1410
DOI: 10.1002/ddr.22100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 15.08.2023. Verfasst von Ning Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Abstract (Originalsprache)
Src homology‐2 domain‐containing protein tyrosine phosphatase‐2 (SHP2) is a key regulatory factor in the cell cycle and its activating mutations play an important role in the development of various cancers, making it an important target for antitumor drugs. Due to the highly conserved amino acid sequence and positively charged nature of the active site of SHP2, it is difficult to discover inhibitors with high affinity for the catalytic site of SHP2 and sufficient cell permeability, making it considered an “undruggable” target. However, the discovery of allosteric regulation mechanisms provides new opportunities for transforming undruggable targets into druggable ones. Given the limitations of orthosteric inhibitors, SHP2 allosteric inhibitors have become a more selective and safer research direction. In this review, we elucidate the oncogenic mechanism of SHP2 and summarize the discovery methods of SHP2 allosteric inhibitors, providing new strategies for the design and improvement of SHP2 allosteric inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.
- Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA Research, Yangzhou, China.
- Department of Oncology, Haian Hospital of Traditional Chinese Medicine, Haian, China.
- School of Life Sciences, Anqing Normal University, Anqing, China.
- Applied Molecular Biology and Biomedicine Lab, Department of Zoology, University of Narowal, Narowal, Pakistan.
ORCID-Profile: Ning Wang
Zitieren
APA
Wang, N., Zhu, S., Lv, D., Wang, Y., Khawar, M. B., & Sun, H. (2023). Allosteric modulation of SHP2: Quest from known to unknown. Drug Development Research, 84(7), 1395-1410. https://doi.org/10.1002/ddr.22100
Vancouver
Wang N, Zhu S, Lv D, Wang Y, Khawar MB, Sun H. Allosteric modulation of SHP2: Quest from known to unknown. Drug Development Research. 2023;84(7):1395-1410. doi:10.1002/ddr.22100
BibTeX
@article{Wang2023,
author = {Wang, Ning and Zhu, Shilin and Lv, Dan and Wang, Yajun and Khawar, Muhammad B and Sun, Haibo},
title = {Allosteric modulation of SHP2: Quest from known to unknown},
journal = {Drug Development Research},
year = {2023},
volume = {84},
number = {7},
pages = {1395--1410},
doi = {10.1002/ddr.22100}
}
EUVIMED